Actively Recruiting
Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-12-04
70
Participants Needed
7
Research Sites
165 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire de Saint Etienne
Lead Sponsor
M
Ministry of Health, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the vibration intervention proposed in the current study is to allow a better neuromotor recovery in subacute stroke patients when compared with standard rehabilitation alone. These last years, it has been proven that the solicitation of a muscle using vibrations may lead to positive effects on the neuromuscular function. Thus, the aim of the current study is to assess if the addition to a standard rehabilitation program of local vibrations sessions of the dorsiflexor muscles of the paretic limb of stroke patients may allow a better recovery of walking speed (primary outcome). One group using vibrations (i.e. experimental group) and one group with sham vibration (i.e. control group) will take part to this study.
CONDITIONS
Official Title
Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke)
- Presenting with a stroke, ischemic or hemorrhagic
- Lower-limb deficiency with an initial motor testing < 4 according to the MRC scale
- No neurological history with functional impact other than stroke
- Having received informed information about the study and having signed the written consent
- Affiliated or entitled to a social security scheme
- Patients under guardianship may be included; they may give their consent with the assistance of their guardian
- If unable to write, consent may be given and documented by other means with an impartial witness who will sign the consent
You will not qualify if you...
- Multiple stroke
- Other neurological, cognitive or psychiatric conditions
- Orthopedic ankle history compromising measurements
- Botulinum toxin injected in the lower limb prior the study protocol
- Patient with phlebitis or risk of thrombosis in the lower limb
- Patient under tutorship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Centre Hospitalier Georges Claudinon
Le Chambon-Feugerolles, France, 42500
Not Yet Recruiting
2
Hôpital Marrel
Rive-de-Gier, France, 42800
Actively Recruiting
3
Centre Hospitalier de Roanne
Roanne, France, 42300
Not Yet Recruiting
4
Service de SSR Val-Rosay
Saint-Didier-au-Mont-d'Or, France, 69370
Not Yet Recruiting
5
Hôpital Bellevue, CHU de Saint-etienne
Saint-Etienne, France, 42100
Actively Recruiting
6
Service de SSR du Centre Le Clos Champirol
Saint-Etienne, France, 42270
Not Yet Recruiting
7
Hospices Civils de Lyon, site Henry Gabrielle
Saint-Genis-Laval, France, 69230
Not Yet Recruiting
Research Team
B
Bruno FERNANDEZ, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here